SPY
735.42
+0.33%
QQQ
656.06
+1.39%
BTC/USD
75,966.89
+0.00%
DIA
509.62
−0.90%
GLD
372.43
−0.81%
TLT
81.81
−0.15%
Try
Free
US
Sign in
Register
My Account
Benzinga
Premium Services
Services
Markets & News
Markets
Stocks & Sectors
Stocks
Ratings & Research
Ratings
Trading
Trading
Screeners & Lists
Screeners
Learn
Learn
Premium Services
Markets & News
Breaking headlines, the trading day, and the calendars that move it.
Stocks & Sectors
Research any ticker, then drill into sectors, ratings, and options.
Ratings & Research
Wall Street calls, insider moves, and Benzinga's own stock rankings.
Trading
Options flow, trade calculators, and ideas for active traders.
Screeners & Lists
Filter the market your way, or start from a curated list.
Learn
Pick a broker, grow your savings, and protect what you've built.
Premium Services
Edge
Ratings, signals & screens
Pro
Real-time news & data terminal
Research
Trade alerts & newsletters
APIs
Market data licensing
All sections
iBio Inc
IBIO
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$0.7301
-0.0699
-8.74%
Last update: Nov 6, 12:03 AM
Get Report
Overview
News
Earnings Forecast
Events
Price Targets
Financials
Sentiment
Ownership
Compare
Stock Report
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga
Edge
Benzinga
Research
Benzinga
Pro
Logout
iBio Financials
iBio (IBIO) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
iBio Q3 EPS $(0.07) Misses $(0.06) Estimate
iBio (AMEX:IBIO) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.06) by 16.67 percent. This is a 85.71 percent increase over losses of $(0.49) per share from the same
Benzinga Newsdesk
iBio Earnings Review: Q2 Summary
Benzinga Insights
PRO
iBio Q2 EPS $(0.09) Misses $(0.07) Estimate
iBio (AMEX:IBIO) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.07) by 28.57 percent. This is a 81.25 percent increase over losses of $(0.48) per share from the same
Benzinga Newsdesk
PRO
iBio Q1 EPS $(0.11) Misses $(0.10) Estimate, Sales $100.000K Beat $25.000K Estimate
iBio (AMEX:IBIO) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.10) by 7.84 percent. This is a 76.09 percent increase over losses of $(0.46) per share from the same
Benzinga Newsdesk
US Stocks Mixed; Coca-Cola Posts Upbeat Earnings
Avi Kapoor
PRO
iBio Q3 EPS $(0.49) Misses $(0.34) Estimate
iBio (AMEX:IBIO) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.34) by 44.12 percent. This is a 30.99 percent increase over losses of $(0.71) per share from the same
Benzinga Newsdesk
